This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Regents of the University of Minnesota. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Raffaello Verardi: Innovator in Cardiac Therapeutics
Introduction
Raffaello Verardi is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of cardiac therapeutics through his innovative research and patent work. His expertise lies in the development of therapeutic polynucleotides aimed at improving myocyte function.
Latest Patents
Raffaello Verardi holds a patent for "Therapeutic polynucleotides, compositions, and methods." This patent describes a composition that includes an xNA molecule comprising at least six nucleotides, which is effective in improving at least one indicator of myocyte function. Additionally, the patent outlines methods for treating cardiac disease by administering this composition to subjects. The methods also include evaluating the efficacy of treatment by adjusting the length of the xNA molecules used in subsequent treatments based on the desired outcomes.
Career Highlights
Verardi is associated with the Regents of the University of Minnesota, where he continues to advance research in cardiac health. His work has the potential to significantly impact the treatment of cardiac diseases, providing new avenues for patient care.
Collaborations
Some of his notable coworkers include Gianluigi Veglia and Brian Raymond Thompson, who contribute to the collaborative research environment at the university.
Conclusion
Raffaello Verardi's innovative work in therapeutic polynucleotides showcases his commitment to improving cardiac health. His contributions are paving the way for new treatment methodologies that could benefit many patients suffering from cardiac diseases.